Nouscom Canvas’ Post

View organization page for Nouscom Canvas, graphic

240 followers

Exciting news! At Nouscom , we're revolutionizing cancer immunotherapy with our cutting-edge heterologous prime/boost platform technology. Our approach, featuring a fantastic great ape adenovirus (GAd) paired with a modified vaccinia virus Ankara (MVA), is unlike anything else out there. What sets us apart? Well, our previous studies have shown that our GAd primes the immune system like nobody's business, while MVA kicks it up a notch, enhancing the response of antigen-specific T cells 🎯 But wait, there's more! We've supercharged our GAd and MVA vectors to carry an unprecedented number of cancer neoantigens, setting a new standard in the field 😮 Why does this matter? Because it means we can more effectively trigger and expand cancer-specific T cells, paving the way for targeted therapies in indications characterized by high tumor mutational burden.  By combining our potent platform with checkpoint inhibitors and other immunomodulators, we're opening up new possibilities in the fight against cancer. Join us on this incredible journey as we push the boundaries of what's possible in cancer treatment! ✨ #CancerImmunotherapy #Innovation #healthcareinnovation #Healthcare #radicalhealth #medicine #cancerawareness

Mirryena Deeb

MD at Mirryena Deeb Associates

5mo

Keep the world informed on your progress! Good luck!

Like
Reply

To view or add a comment, sign in

Explore topics